[{"address1": "Royal Bank Plaza", "address2": "Suite 2800 South Tower 200 Bay Street", "city": "Toronto", "state": "ON", "zip": "M5J 2J1", "country": "Canada", "phone": "647-660-1780", "website": "https://satellos.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Satellos Bioscience Inc., a biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases. Its lead program focuses on the discovery and development of a small molecule drug for the treatment of duchenne. The company's MyoReGenX, an automated microscopy system which recapitulates the muscle stem cell environment ex-vivo. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Francis  Gleeson B.B.A. M.B.A", "age": 68, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1955, "fiscalYear": 2022, "totalPay": 197266, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael A. Rudnicki Ph.D.", "age": 61, "title": "Co-Founder & Chief Discovery Officer", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": 88398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Lambert M.A., Ph.D.", "age": 54, "title": "Chief Scientific Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 49652, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. William Wasyl Jarosz", "age": 67, "title": "Executive Director", "yearBorn": 1956, "fiscalYear": 2022, "totalPay": 142755, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warren  Whitehead C.M.A., CPA", "age": 71, "title": "Head of Corporate Strategy", "yearBorn": 1952, "fiscalYear": 2022, "totalPay": 88398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth  Williams CA, CPA", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. J. Robert Hall CFA", "title": "Senior Vice President of Finance & Administration", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ryan  Mitchell Ph.D.", "title": "Vice President of Corporate Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Liggett B.Sc., Bsc. Pharm., C.A., C.P.A., CA, CPA", "age": 63, "title": "Strategic Advisor", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 32768, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Desiree  Chan", "title": "Chief of Staff", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.5242, "open": 0.4973, "dayLow": 0.473, "dayHigh": 0.4973, "regularMarketPreviousClose": 0.5242, "regularMarketOpen": 0.4973, "regularMarketDayLow": 0.473, "regularMarketDayHigh": 0.4973, "beta": 1.33, "forwardPE": -4.73, "volume": 1900, "regularMarketVolume": 1900, "averageVolume": 14440, "averageVolume10days": 8820, "averageDailyVolume10Day": 8820, "marketCap": 53350616, "fiftyTwoWeekLow": 0.22, "fiftyTwoWeekHigh": 0.59, "fiftyDayAverage": 0.4031, "twoHundredDayAverage": 0.36077, "currency": "USD", "enterpriseValue": 14862387, "floatShares": 88567394, "sharesOutstanding": 112792000, "heldPercentInsiders": 0.17558001, "heldPercentInstitutions": 0.0088599995, "impliedSharesOutstanding": 118648000, "bookValue": 0.411, "priceToBook": 1.1508515, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -14425437, "trailingEps": -0.18, "forwardEps": -0.1, "lastSplitFactor": "1:20", "lastSplitDate": 1629244800, "enterpriseToEbitda": -1.303, "52WeekChange": 0.8714286, "SandP52WeekChange": 0.27220368, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "MSCLF", "underlyingSymbol": "MSCLF", "shortName": "SATELLOS BIOSCIENCE INC", "longName": "Satellos Bioscience Inc.", "firstTradeDateEpochUtc": 1344000600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "48842655-835e-3cc4-bfca-60f3fe40b54a", "messageBoardId": "finmb_650365067", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.473, "targetHighPrice": 0.7, "targetLowPrice": 0.7, "targetMeanPrice": 0.7, "targetMedianPrice": 0.7, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 44263000, "totalCashPerShare": 0.392, "ebitda": -11404671, "quickRatio": 19.257, "currentRatio": 19.291, "returnOnAssets": -0.24242, "returnOnEquity": -0.52875, "freeCashflow": -5550582, "operatingCashflow": -10258347, "financialCurrency": "CAD", "trailingPegRatio": null}]